NeuroPace (NPCE) EBIAT (2020 - 2025)
Historic EBIAT for NeuroPace (NPCE) over the last 6 years, with Q3 2025 value amounting to -$3.5 million.
- NeuroPace's EBIAT rose 3587.67% to -$3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$24.0 million, marking a year-over-year increase of 1461.32%. This contributed to the annual value of -$27.1 million for FY2024, which is 1764.47% up from last year.
- Latest data reveals that NeuroPace reported EBIAT of -$3.5 million as of Q3 2025, which was up 3587.67% from -$8.7 million recorded in Q2 2025.
- In the past 5 years, NeuroPace's EBIAT ranged from a high of -$3.5 million in Q3 2025 and a low of -$12.7 million during Q2 2022
- Moreover, its 5-year median value for EBIAT was -$8.7 million (2025), whereas its average is -$8.5 million.
- Its EBIAT has fluctuated over the past 5 years, first crashed by 13155.05% in 2021, then skyrocketed by 4437.47% in 2023.
- Quarter analysis of 5 years shows NeuroPace's EBIAT stood at -$10.7 million in 2021, then dropped by 4.24% to -$11.1 million in 2022, then surged by 44.37% to -$6.2 million in 2023, then grew by 15.32% to -$5.2 million in 2024, then soared by 33.41% to -$3.5 million in 2025.
- Its EBIAT was -$3.5 million in Q3 2025, compared to -$8.7 million in Q2 2025 and -$6.6 million in Q1 2025.